Trials / Conditions / Gangliosidoses, GM2
Gangliosidoses, GM2
3 registered clinical trials studyying Gangliosidoses, GM2 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile For NCT07082543 | Azafaros A.G. | Phase 3 |
| Completed | Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease) NCT01102686 | The Hospital for Sick Children | Phase 1 / Phase 2 |
| Completed | Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis NCT00418847 | The Hospital for Sick Children | Phase 2 |